Table 1 Patient demographics and clinical characteristics, overall and according to phase of depression
|  | All patients (N = 752) | Acute (n = 300) | Remission (n = 452) |
|---|---|---|---|
Sex, n (%) | |||
 Female | 466 (62)a | 195 (65)a | 271 (60)a |
Age, years | |||
 Mean (SD) | 45 (12) | 45 (12) | 46 (13) |
Time since diagnosis of depression (months) | |||
 Mean (SD) | 62.4 (49.5) | 61.3 (48.3) | 63.2 (50.3) |
High school education or above, n (%) | 596 (79) | 235 (78) | 361 (80) |
Work status, n (%) | |||
 Full-time | 348 (46) | 120 (40) | 228 (50)** |
 Part-time | 93 (12) | 33 (11) | 60 (13) |
In a relationship, n (%) | 471 (63) | 181 (60) | 290 (64) |
Current antidepressant treatment, n (%)b | |||
 Fluoxetine | 199 (26) | 87 (29) | 112 (25) |
 Escitalopram | 125 (17) | 52 (17) | 73 (16) |
 Sertraline | 121 (16) | 53 (18) | 68 (15) |
 Citalopram | 110 (15) | 48 (16) | 62 (14) |
 Venlafaxine | 100 (13) | 46 (15) | 54 (12) |
 Bupropion | 79 (11) | 46 (15)** | 33 (7) |
 Paroxetine | 78 (10) | 32 (11) | 46 (10) |
Clinical assessment scores, mean (SD) | |||
 ODQ total score | 89.3 (18.3) | 94.8 (16.6)** | 85.7 (18.4) |
 FAST total score | 38.7 (17.3) | 47.0 (15.8)** | 33.5 (16.1) |
 WHO-5 total score | 8.5 (5.5) | 6.4 (5.6)** | 9.8 (5.0) |